ArticlePloS one2024

Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis.

Luciano Adorini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.